Avenue Net Income vs Cash And Cash Equivalents Changes Analysis
| ATXI Stock | USD 2.08 0.07 3.48% |
Avenue Therapeutics financial indicator trend analysis is way more than just evaluating Avenue Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Avenue Therapeutics is a good investment. Please check the relationship between Avenue Therapeutics Net Income and its Cash And Cash Equivalents Changes accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avenue Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more detail on how to invest in Avenue Stock please use our How to Invest in Avenue Therapeutics guide.
Net Income vs Cash And Cash Equivalents Changes
Net Income vs Cash And Cash Equivalents Changes Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Avenue Therapeutics Net Income account and Cash And Cash Equivalents Changes. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Avenue Therapeutics' Net Income and Cash And Cash Equivalents Changes is 0.17. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Cash And Cash Equivalents Changes in the same time period over historical financial statements of Avenue Therapeutics, assuming nothing else is changed. The correlation between historical values of Avenue Therapeutics' Net Income and Cash And Cash Equivalents Changes is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of Avenue Therapeutics are associated (or correlated) with its Cash And Cash Equivalents Changes. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Cash Equivalents Changes has no effect on the direction of Net Income i.e., Avenue Therapeutics' Net Income and Cash And Cash Equivalents Changes go up and down completely randomly.
Correlation Coefficient | 0.17 |
| Relationship Direction | Positive |
| Relationship Strength | Insignificant |
Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Avenue Therapeutics financial statement analysis. It represents the amount of money remaining after all of Avenue Therapeutics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Cash And Cash Equivalents Changes
Most indicators from Avenue Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Avenue Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avenue Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more detail on how to invest in Avenue Stock please use our How to Invest in Avenue Therapeutics guide.The Avenue Therapeutics' current Issuance Of Capital Stock is estimated to increase to about 7.9 M, while Selling General Administrative is projected to decrease to under 3.3 M.
Avenue Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Avenue Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Avenue Therapeutics fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 8.9M | 3.2M | 4.0M | 6.8M | 1.9M | 1.8M | |
| Other Current Liab | 1.7M | 714K | 147K | 3.4M | 795K | 1.1M | |
| Total Current Liabilities | 2.1M | 886K | 509K | 3.6M | 1.2M | 2.2M | |
| Total Stockholder Equity | 6.8M | 2.4M | 3.5M | 3.9M | 1.6M | 2.9M | |
| Net Tangible Assets | (631K) | 6.8M | 2.4M | 3.5M | 4.0M | 2.8M | |
| Net Debt | (8.7M) | (3.1M) | (3.8M) | (6.7M) | (1.8M) | (1.9M) | |
| Retained Earnings | (68.1M) | (73.3M) | (77.0M) | (80.6M) | (90.9M) | (86.4M) | |
| Accounts Payable | 368K | 172K | 362K | 150K | 401K | 778.9K | |
| Cash | 8.7M | 3.1M | 3.8M | 6.7M | 1.8M | 1.7M | |
| Cash And Short Term Investments | 8.7M | 3.1M | 3.8M | 6.7M | 1.8M | 1.7M | |
| Common Stock Shares Outstanding | 1.0M | 1.1M | 1.1M | 2.2M | 141.2K | 134.2K | |
| Liabilities And Stockholders Equity | 8.9M | 3.2M | 4.0M | 6.8M | 1.9M | 1.8M | |
| Non Current Liabilities Total | 0.0 | 3.6M | 368K | 172K | 362K | 949.0 | |
| Capital Surpluse | 38.9M | 41.6M | 74.9M | 75.6M | 87.0M | 91.3M | |
| Other Stockholder Equity | 74.9M | 75.6M | 80.4M | 84.5M | 92.5M | 59.9M | |
| Total Liab | 2.1M | 886K | 509K | 3.6M | 1.2M | 1.1M | |
| Total Current Assets | 8.9M | 3.2M | 4.0M | 6.8M | 1.9M | 1.8M | |
| Other Assets | 1.9M | 170K | 113K | 137.0 | 67K | 63.7K | |
| Other Current Assets | 170K | 113K | 107K | 137K | 67K | 129.6K | |
| Net Invested Capital | 6.8M | 2.4M | 3.5M | 3.9M | 1.6M | 1.5M | |
| Net Working Capital | 6.8M | 2.4M | 3.5M | 3.3M | 654K | 621.3K |
Currently Active Assets on Macroaxis
When determining whether Avenue Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Avenue Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Avenue Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Avenue Therapeutics Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avenue Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more detail on how to invest in Avenue Stock please use our How to Invest in Avenue Therapeutics guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avenue Therapeutics. If investors know Avenue will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avenue Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.76) | Earnings Share 24.78 | Return On Assets (2.01) | Return On Equity (5.35) |
The market value of Avenue Therapeutics is measured differently than its book value, which is the value of Avenue that is recorded on the company's balance sheet. Investors also form their own opinion of Avenue Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Avenue Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avenue Therapeutics' market value can be influenced by many factors that don't directly affect Avenue Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avenue Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avenue Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avenue Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.